Health-care transition after Kawasaki disease in patients with coronary artery lesion

Hiroshi Kamiyama1,2, Mamoru Ayusawa1, Shunichi Ogawa3

  • 1Department of Pediatrics and Child Health, Nihon University School of Medicine, Itabashi, Japan.

Insights

Health-care transition for adults with childhood coronary artery lesions (CAL) after Kawasaki disease (KD) faces challenges. Over 40% experienced loss to follow-up, highlighting the need for improved pediatrician-cardiologist collaboration.

Area of Science:

  • Cardiology
  • Pediatrics
  • Health Services Research

Background:

  • Kawasaki disease (KD) can cause coronary artery lesions (CAL) in children.
  • Successful health-care transition (HCT) is crucial for adults with childhood CAL.
  • Understanding HCT realities and loss to follow-up is essential for patient outcomes.

Purpose of the Study:

  • To investigate the current state of HCT for adults with a history of CAL post-KD.
  • To identify the extent of loss to follow-up during the HCT process.

Main Methods:

  • A nationwide online questionnaire survey was conducted among members of the Japanese Society of Kawasaki Disease.
  • Data were collected from May to July 2014, with a response rate of 83.3%.

Main Results:

  • Over 90% of respondents manage patients requiring HCT, with 55% having completed HCT for some patients.
  • More than 40% of respondents reported loss to follow-up in HCT.
  • Most respondents viewed HCT care provided by cardiologists favorably and supported continued pediatrician-cardiologist information sharing.

Conclusions:

  • Adult cardiologists are increasingly managing patients with CAL post-KD.
  • Pediatricians should develop support programs and collaborate with cardiologists to improve HCT and reduce loss to follow-up.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
430
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
736
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
374